Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis

OBJECTIVES: Pulmonary fibrosis is a leading cause of death in systemic sclerosis (SSc). This report examines the differences at baseline and over 12 months between patients with limited versus diffuse cutaneous SSc who participated in the Scleroderma Lung Study. METHODS: SSc patients (64 limited; 94...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Clements, P J, Roth, M D, Elashoff, R, Tashkin, D P, Goldin, J, Silver, R M, Sterz, M, Seibold, J R, Schraufnagel, D, Simms, R W, Bolster, M, Wise, R A, Steen, V, Mayes, M D, Connelly, K, Metersky, M, Furst, D E
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Group 2007
Предметы:
Extended Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2095310/
https://ncbi.nlm.nih.gov/pubmed/17485423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2007.069518
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы